KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Opko Health (OPK) over the last 16 years, with Q3 2025 value amounting to -$624000.0.

  • Opko Health's Change in Inventory rose 8677.97% to -$624000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $7.5 million, marking a year-over-year increase of 14284.17%. This contributed to the annual value of -$4.2 million for FY2024, which is 7225.11% up from last year.
  • Per Opko Health's latest filing, its Change in Inventory stood at -$624000.0 for Q3 2025, which was up 8677.97% from $478000.0 recorded in Q2 2025.
  • In the past 5 years, Opko Health's Change in Inventory registered a high of $27.9 million during Q1 2021, and its lowest value of -$24.1 million during Q2 2021.
  • For the 5-year period, Opko Health's Change in Inventory averaged around -$3.1 million, with its median value being -$1.4 million (2023).
  • As far as peak fluctuations go, Opko Health's Change in Inventory crashed by 37338.16% in 2023, and later surged by 33909.41% in 2025.
  • Opko Health's Change in Inventory (Quarter) stood at -$16.4 million in 2021, then skyrocketed by 85.71% to -$2.3 million in 2022, then plummeted by 373.38% to -$11.1 million in 2023, then soared by 120.11% to $2.2 million in 2024, then plummeted by 127.92% to -$624000.0 in 2025.
  • Its last three reported values are -$624000.0 in Q3 2025, $478000.0 for Q2 2025, and $5.4 million during Q1 2025.